Related Experiment Video

Updated: Aug 8, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
12:07

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation

Published on: September 20, 2010

[Cognitive disorders in AIDS: clinical, virological and neuroradiological features]

B Stankoff1, S Suarez, O Rosemblum

  • 1Fédération de Neurologie, Hôpital de la Salpêtrière, Paris.

Revue Neurologique
|February 5, 1999
PubMed

Insights

HIV-associated neurocognitive disorders (HAND) manifest as cognitive impairment, particularly in late-stage, immunosuppressed patients. Research is ongoing to understand the role of HIV load and new treatments for HAND.

Area of Science:

  • Neurology
  • Infectious Diseases
  • Neuroscience

Context:

  • HIV-associated neurocognitive disorders (HAND) are frequently observed in advanced HIV infection stages.
  • Patients often present with subcortical cognitive impairment, characterized by slowed motor speed and memory deficits.
  • Encephalic MRI typically reveals diffuse leucoencephalopathy, with variable correlation to clinical symptoms.

Purpose:

  • To investigate the clinical presentation and diagnostic challenges of HAND.
  • To explore the potential of HIV load in blood and cerebrospinal fluid as diagnostic and prognostic markers.
  • To assess the uncertain efficacy of novel antiretroviral therapies on HIV dementia.

Summary:

  • HAND presents as subcortical cognitive impairment with psychomotor slowing and memory issues in immunosuppressed individuals.
  • Neuroimaging often shows diffuse leucoencephalopathy, but clinical and radiological findings may not correlate well.
  • The diagnostic/prognostic value of viral load and the impact of new antiretrovirals on HIV dementia are under investigation.

Impact:

  • Highlights the need for better diagnostic tools for HAND.
  • Underscores the importance of monitoring viral load in neurological contexts.
  • Emphasizes the ongoing search for effective treatments for HIV-related cognitive decline.

More Related Videos

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation10:04

Quantification of Cerebral Vascular Architecture using Two-photon Microscopy in a Mouse Model of HIV-induced Neuroinflammation

Published on: January 13, 2016

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...